A detailed history of Morgan Stanley transactions in Zynex Inc stock. As of the latest transaction made, Morgan Stanley holds 92,966 shares of ZYXI stock, worth $829,256. This represents 0.0% of its overall portfolio holdings.

Number of Shares
92,966
Previous 110,226 15.66%
Holding current value
$829,256
Previous $1.2 Million 4.25%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$9.86 - $13.74 $170,183 - $237,152
-17,260 Reduced 15.66%
92,966 $1.15 Million
Q4 2023

Feb 13, 2024

SELL
$7.1 - $10.89 $187,972 - $288,312
-26,475 Reduced 19.37%
110,226 $1.2 Million
Q3 2023

Nov 15, 2023

SELL
$6.95 - $9.89 $1.71 Million - $2.44 Million
-246,285 Reduced 64.31%
136,701 $1.09 Million
Q2 2023

Aug 14, 2023

BUY
$8.59 - $14.56 $1.32 Million - $2.24 Million
153,621 Added 66.98%
382,986 $3.67 Million
Q1 2023

May 15, 2023

SELL
$9.53 - $16.8 $127,816 - $225,321
-13,412 Reduced 5.52%
229,365 $2.75 Million
Q4 2022

Feb 14, 2023

SELL
$8.71 - $14.28 $48,296 - $79,182
-5,545 Reduced 2.23%
242,777 $3.38 Million
Q3 2022

Nov 14, 2022

SELL
$7.19 - $9.91 $766,820 - $1.06 Million
-106,651 Reduced 30.04%
248,322 $2.25 Million
Q2 2022

Oct 27, 2022

BUY
$5.78 - $8.87 $650,319 - $997,981
112,512 Added 46.4%
354,973 $2.83 Million
Q2 2022

Aug 15, 2022

BUY
$5.78 - $8.87 $650,319 - $997,981
112,512 Added 46.4%
354,973 $2.83 Million
Q1 2022

Oct 27, 2022

SELL
$5.14 - $9.35 $578,311 - $1.05 Million
-112,512 Reduced 31.7%
242,461 $1.51 Million
Q1 2022

May 13, 2022

BUY
$5.14 - $9.35 $741,506 - $1.35 Million
144,262 Added 146.91%
242,461 $1.51 Million
Q4 2021

Feb 14, 2022

BUY
$8.71 - $13.77 $65,203 - $103,082
7,486 Added 8.25%
98,199 $980,000
Q3 2021

Nov 15, 2021

BUY
$10.35 - $15.65 $938,879 - $1.42 Million
90,713 New
90,713 $1.03 Million

Others Institutions Holding ZYXI

About ZYNEX INC


  • Ticker ZYXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 37,453,400
  • Market Cap $334M
  • Description
  • Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...
More about ZYXI
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.